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Objectives: The aim of this study was to establish a list of priority topics for methods
research to support decision making at the National Institute for Health and Clinical
Excellence (NICE).
Methods: Potential priorities for methods research topics were identified through a
focused literature review, interviews, an email survey, a workshop and a Web-based
feedback exercise. Participants were members of the NICE secretariat and its advisory
bodies, representatives from academia, industry, and other organizations working closely
with NICE. The Web exercise was open to anyone to complete but publicized among the
above groups.
Results: A list of potential topics was collated. Priorities for further research differed
according to the type of respondent and the extent to which they work directly with NICE.
Priorities emerging from the group closest to NICE included: methodology for indirect and
mixed treatment comparisons; synthesis of qualitative evidence; research relating to the
use of quality-adjusted life-years (QALYs) in decision making; methods and empirical
research for establishing the cost-effectiveness threshold; and determining how data on
the uncertainty of effectiveness and cost-effectiveness data should be taken into account
in the decision-making process. Priorities emerging from the broadest group of
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respondents (through the Web exercise) included: methods for extrapolating beyond
evidence observed in trials, methods for capturing benefits not included in the QALY and
methods to assess when technologies should be recommended in the context of further
evidence gathering.
Conclusions: Consideration needs to be given to the needs of those who use the outputs
of research for decision making when determining priorities for future methods research.
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The National Institute for Health and Clinical Excellence
(NICE) is established within the National Health Service
(NHS) as an organization that makes evidence-based deci-
sions regarding the effective use of NHS resources (2). It
aims to produce guidance based on the best available evi-
dence and using processes that are transparent, collabora-
tive and involve its stakeholders. In addition, the methods
NICE adopts are subject to regular and close scrutiny, and
have been the subject of some criticism (3;5). For example,
in a review of NICE by a UK parliamentary Health Select
Committee in 2007, it was noted that, although NICE’s eval-
uation procedures had been shown to be generally robust,
problems were perceived in the methods it uses and the need
for further methodological research was communicated (4).
Areas for improvement included topic selection, the evidence
base available to NICE, the timeliness of the publication of
guidance and the measurement of the costs and benefits of
health interventions. Similarly, in his review of UK health
research funding, Sir David Cooksey (1) also noted the need
for further research into health technology assessment (HTA)
methodology to support the work of NICE.
NICE has four main guidance producing programs: clin-
ical guidelines; technology appraisals; public health; and in-
terventional procedures. One important difference between
these programs is that the interventional procedures program
focuses on the safety and efficacy of interventions, but does
not include a consideration of cost-effectiveness, whereas
this information is routinely considered in the other three
programs. Methods guides for each program describe the
analytical techniques and processes used to produce NICE
guidance. NICE has stated a commitment to using the most
up-to-date methods for its evaluations (8) and the meth-
ods guides are reviewed regularly (7;10). As with similar
healthcare evaluation agencies, the NICE methods review
process may highlight specific methodological areas that re-
quire further research. However, a comprehensive review
of priorities for methodological research to help facilitate
NICE decision making has not previously been conducted.
The aim of this review was to establish an initial list of
priority methods research topics to support NICE decision
making. This review was conducted as part of a broader
project which also included an evaluation of the processes
by which such priorities are identified and prioritized by
NICE; the results of this aspect of the project are reported
elsewhere (6).
METHODS
Overview
A variety of methods were adopted to obtain the views of
a range of NICE stakeholders with an interest in evalua-
tion and NICE. A focused literature review aimed to obtain
information on NICE’s research needs as reported by evalua-
tion experts and from government-related reviews relating to
NICE’s work. Interviews were used to obtain detailed infor-
mation from key members of NICE and organizations closely
allied to it. An email survey was used to capture the views of
a broader group from NICE, its stakeholders and HTA and
health evaluation organizations within and outside of the UK.
Finally, a workshop was convened and a Web-based exercise
conducted to get feedback on a long list of topics collated at
each stage of the project.
Topic suggestions were limited to research into methods
to support NICE decision making. A reasonably broad view
of what constitutes methodological research was adopted;
however, purely empirical research relating to specific health
conditions was excluded. Suggestions for topics came from
each element of the project and duplicate suggestions were
deleted or merged where this was possible.
Literature Review
A focused literature review was conducted to identify po-
tential methods research topics relating to NICE’s decision-
making activity. The review included key policy documents
identified by the project team and its advisory group. The
review of the literature included recent key policy docu-
ments relating to the work of NICE and a focused review of
NHSEED (which searches MEDLINE and EMBASE) and
the Cochrane Methodology register. Search terms were re-
stricted to methodology, method, and methods and papers
published between 2004 and 2008. This was supplemented
by a review of the literature conducted by NICE for its tech-
nical staff (the “What’s New” bulletin), reviews of abstracts
from NICE conferences and articles identified by the ex-
tended project team. In addition, the NICE Methods Guides
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and supporting documentation from the 2008 review of the
NICE Technology Appraisals were reviewed (comparable
supporting documentation was not available for the other
NICE programs). Full details of the search strategies are re-
ported elsewhere (6).
For inclusion, papers had to address methodological is-
sues explicitly related to NICE decision making and/or the
processes used at NICE to develop or promote methodolog-
ical research. All titles and abstracts were reviewed by two
reviewers and any disagreement resolved through discussion.
Interviews
A series of interviews was conducted with representatives
from NICE (including the Directors of each of the guidance
programs, the R&D program and the Patient and Public In-
volvement Program), its advisory bodies and representatives
from organizations that work closely with NICE and/or pro-
vide evidence to inform its decision making (for example,
the Association of British Pharmaceutical Industries and the
National Institute for Health Research Health Technology
Assessment program). Interviewees were identified by the
project team in collaboration with advisors from NICE. In-
terviews were semi-structured and conducted by telephone
or in-person. Interviewees were asked to suggest up to five
topics for methods research that they considered to be most
important to assist the NICE decision-making process. They
were also asked why the suggested topics were important
and how they could contribute to NICE’s work.
Email Survey
The interview schedule was translated into a survey which
was sent by e-mail to a wider group of thirty-three people
that work with NICE. Recipients of the email survey were
agreed with NICE and included Associate Directors and se-
nior technical staff working at NICE, the academic groups
who conduct reviews of the evidence for NICE, representa-
tives of key evidence/research collaborations in the United
Kingdom (such as the Cochrane Collaboration), and repre-
sentatives of a selection of similar organizations outside of
the UK (such as the Agency for Healthcare Research and
Quality in the United States).
Workshop
A workshop was convened with the objective of clarifying
and refining the list of potential methodology research top-
ics identified by the focused literature review, interviews and
email survey. Participants included members of NICE staff
and its advisory committees, representatives from the aca-
demic groups conducting evidence reviews for NICE, in-
dustry, and methodologists. In preparation for the workshop,
topics were grouped into key areas of methodology by one
of the authors (L.L.) and reviewed by the rest of the project
team. Consensus about any differences was reached through
discussion. Topics that related to more than one area were
categorized into to the one which was considered most rele-
vant.
Following a series of presentations on the general topic
areas, participants discussed some of the topics in small
groups. Participants were specifically asked to consider
which of the potential research topics were most important
and to discuss the topics in relation to the following five key
questions. (i) Do they address challenges faced by NICE? (ii)
How can they add value to NICE’s role? (iii) Can questions
be further defined? (iv) Are there additional topics? (v) What
should be the initial prioritization?
Web-Based Feedback Exercise
The categorization of topics into methodological areas was
revised following feedback during the workshop. The final
long list of topics was made available by means of the UK
Medical Research Council (MRC) Web site in the form of
a feedback questionnaire. A link to the Web site was sent
to NICE staff, members of NICE advisory bodies, and those
invited to participate in earlier stages of the project, including
the workshop. The feedback questionnaire was also publicly
advertised on the NICE and MRC Web sites. Respondents
were asked to rate each topic on a scale of very important,
important, fairly important and not important. They were
also given the opportunity to nominate any other topics. Re-
spondents were asked to rank their top three priorities and to
provide information on how each could help improve deci-
sion making at NICE. Equal weight was given to the response
of each respondent.
Further Analysis
Each stage of the project involved slightly different groups
of individuals, some of whom work directly with NICE to
varying degrees: the interviews focused on NICE and those
involved closely with it; the email survey included larger
group of these people, researchers providing evidence to in-
form NICE decisions and representatives from other similar
agencies; in addition to these groups, the workshop and Web-
feedback exercise included broader groups of people from in-
dustry and academia. Therefore, the responses at each stage
of this review are analyzed separately. The following defini-
tions were used to identify high priority topics at each stage
of the project: (i) Topics independently suggested by two
or more people during the interview stage (the group clos-
est aligned to NICE); (ii) Topics raised more than twice as
most important during the group discussions at the workshop
(slightly broader group including methodologists with links
to NICE); (iii) Topics that were rated as important or very
important by 75 percent or more of respondents (the broad-
est group, which included people who may have no direct
professional links to NICE).
The relevance of each topic in relation to each of the
NICE guidance producing programs and in relation to key
activities in production of guidance was considered. The
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Table 1. Number of Invitations to Participate in Interviews and Email Survey and Responses by Type of
Organization
Interviews Email survey
Type of organization No. invited Interviewed No. sent survey No. completed
NICE secretariat 7 7 5 4
NICE advisory body (Chair) 5 4 0 0
Academic group conducting reviews for NICE 2 2 11 6
Pharmaceutical or medical device industry 3 3 0 0
Devolved government administrations (health department) 0 0 4 0
National research organization (President/Chair) 1 1 4 1
National government agency 1 1 3 0
International health technology assessment organizations 0 0 6 2
Total 19 18 33 13
Percentage response rate 95% 39%
topics were categorized by one of the authors (L.L.) ac-
cording to their relevance to one or more of the four NICE
guidance programs. In addition the topics were again catego-
rized according to one of six key activities within the guid-
ance production process they most closely related: (i) scoping
the question to be addressed by the guidance, (ii) evidence
synthesis, (iii) primary data collection and/or analysis, (iv)
economic analysis, (v) engagement with stakeholders and;
(vi) decision making. The categorization was checked by
other members of the project and any disagreement resolved
through discussion.
RESULTS
Literature Review
A total 1,150 journal articles were screened. After initial
screening, nineteen journal articles were reviewed in full
alongside twenty-two policy documents and NICE process
documents. Of these, eleven specific suggestions for methods
research topics explicitly addressing the work of NICE were
identified.
Response Rates
Eighteen interviews were conducted. Of thirty-three invited
email-survey respondents, thirteen (39 percent) completed
surveys were received. Although the response rate is low,
there was a reasonable response rate from NICE employees
(60 percent), UK HTA and health evaluation methodolo-
gists, and representatives from academic groups conducting
evidence reviews for NICE (75 percent). Two representatives
from other evidence/research collaborations responded that
they did not believe that they were sufficiently informed re-
garding NICE to complete the survey. Seventy-six responses
to the Web feedback exercise were received. Details of re-
sponses to the interviews and email survey are provided in
Table 1. Most respondents to the Web feedback exercise were
based in universities (66 percent); others included NICE (13
percent), pharmaceutical industry (9 percent), the NHS (7
percent), and others (5 percent). Their professional back-
grounds included health services researchers (32 percent),
health economists (26 percent), clinicians (13 percent), pub-
lic health specialists (9 percent), and others (20 percent).
Further details on the respondents are reported elsewhere
(6).
Research Topic Suggestions
Over 100 topics for potential methodological research were
identified through the interviews, email survey and focused
review of the literature. There were similarities and over-
lap between some of the suggestions. To accommodate
this and to facilitate discussion at the workshop, the sug-
gested topics were grouped into themes under five general
areas of methodology. The general areas of methodology
and themes under which each of the topics were grouped
are shown in Box 1 and the full list of topics is shown
in Supplementary Table 1, which can be viewed online at
www.journals.cambridge.org/thc2011011.
Relevance of Topics to NICE Activities
and Programs
Approximately 45 percent of topics were relevant to all four
of NICE’s programs. A further 38 percent of topics sug-
gested research aimed at the three guidance producing pro-
grams that routinely consider cost-effectiveness as part of
their processes (clinical guidelines, public health, and tech-
nology appraisals). The remainder of topics were specific to
one or more of the NICE programs.
The largest proportions of topics most closely related
to economic analysis (41 percent) and evidence synthe-
sis (32 percent). Activities relating to decision making
(either the process of decision making or the considera-
tions that should be taken into account when making de-
cisions/recommendations) accounted for 19 percent of topic
suggestions. Scoping, primary data collection/analysis, and
engagement with stakeholders accounted for only 2 percent,
2 percent, and 5 percent of suggestions, respectively. Further
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Box 1: Areas and Themes under which Methodological
Research Questions Were Grouped
Area 1: Analysis and design of effectiveness studies and their
synthesis
A. Systematic reviews
B. Meta -analysis (including indirect and mixed treatment
comparisons)
C. Use of non-experimental data
D. Interpretation and analysis of clinical trial data
E. Clinical heterogeneity
F. Diagnostics and medical devices
G. Behavioural research
Area 2: Synthesis of evidence from patients, the public and
stakeholders
A. Evidence from patients
B. Evidence from the general public
C. Evidence from stakeholders
Area 3: Economic analysis and uncertainty
A. Costing
B. Perspective for analysis
C. Time horizon for analysis
D. Economic modelling
E. Uncertainty
F. Other
Area 4: Measurement and valuation of benefits
A. Use of the QALY
B. Standardised measurement tools
C. Valuation of health
D. Use of health state utility data in economic models
Area 5: Decision-making at NICE
A. Threshold for cost–effectiveness
B. Influences on NICE decision-making
C. Handling uncertainty in decision-making
D. Process of decision-making
E. Developing the format/type of NICE recommendations
details on the relationship between the topic suggestions and
NICE programs and activities are reported elsewhere (6).
Priority Topics
The topics emerging as priorities from each stage of the
process are shown in Table 2. No topics were consistently
prioritized at all three stages of the project; however, some
were common to more than one stage. For example, methods
for determining empirically the cost-effectiveness threshold
were identified as a priority in the interviews and work-
shop. Methods for conducting efficient systematic reviews,
extrapolating costs and benefits, and capturing wider bene-
fits outside the QALY were all identified by the workshop
participants and responders to the Web survey.
Table 3 shows the topics most frequently rated as impor-
tant or very important in the Web feedback to the type of orga-
nization to which the respondent belongs (NICE, university,
Industry, other). Although based on small numbers, it shows
that those topics considered most important differ between
the types of organization. Industry and “other” respondents
(who were mainly from the NHS) rated a larger number of
topics as important. There was consensus among the NICE
respondents that research to establish when NICE should rec-
ommend a treatment in the context of research is important.
However, only 63 percent of the other respondents consid-
ered this to be important. Establishing efficient methods for
conducting systematic reviews was considered important by
92 percent of NICE respondents, but by only 63 percent
of the non-NICE respondents. In addition, those responding
to the Web-feedback exercise requested respondents to list
their top three research topics. The ranking section of the
feedback questionnaire was completed by 72 percent of re-
spondents. The most common topics ranked in the top three
were: methods to evaluate interventions to change behavior
in the context of public health (n = 13), Methods for con-
ducting systematic reviews of complex interventions (n = 7)
and establishing efficient methods for conducting systematic
reviews (n = 6).
DISCUSSION
A list of potential research methodological research topics
to improve the methods used by NICE to produce guidance
has been collated. Across the five areas into which topics
were arranged, there appears to be a broad relevance across
the range of NICE’s decision-making activities. Research
priorities were identified by different groups of individuals,
with varying degrees of links to NICE, at specific stages of the
project. There were some differences in the topics identified
as most important between the groups.
The project was conducted within tight time and resource
constraints to inform a specific call for research funding by
the NIHR MRC methodology panel. The literature review
was highly focused to achieve this. Ideally the review would
have extended to literature relating to processes and methods
priorities for organizations similar to NICE internationally
and possibly to the extensive methods literature relating to the
evaluation of health services and medical technologies. How-
ever, it is unclear whether the methods research topics that
might have emerged from this additional work would have
directly applied to NICE’s activities. In addition, the other
stages of the review were used to identify any topics missed
from the literature review. The Web-based survey to prior-
itize potential topics was limited by time—it was available
for completion for a period of a month. It is likely that this
time constraint, and the extensive length of the questionnaire
which reflected the number of potential topics identified in
earlier stages of the project, limited the number of responses
for analysis. Despite these limitations, the Web comment pro-
vides some indication of how important the suggested topics
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Table 2. Topics Emerging as Priorities at Different Stages
Project stage Priority topics
Interviews and
email
survey
• Methodology for indirect and mixed treatment comparisons
• Synthesis of qualitative evidence in the NICE decision-making process
• Use of quality-adjusted life-years (QALYs) in decision making (specifically establishing what benefits of
treatment are not captured by the QALY and/or standardized measures of health-related quality of life)
• Establishing the threshold for cost-effectiveness (including the appropriate methods for estimating this)
• Determining how data on the uncertainty of effectiveness and cost-effectiveness data should be taken into
account in the decision-making process
Workshop • Methods for keeping research synthesis up to date (including developing repositories of ‘approved’ networks
of evidence in key diseases)
• Methods to assess what types of evidence from patients should be used at different stages of NICE’s
decision-making processes (e.g., when to undertake reviews of qualitative evidence? When should colloquial
evidence be used?)
• Extrapolation of estimates of the costs and benefits of interventions beyond those observed in trials, including
the quantification of uncertainty
• Establishing what effects of interventions and programs are/are not currently captured by the EQ-5D
• Methods for the re-evaluation of the EQ-5D preference set for the UK population with consideration to (i) the
use of patient valuations of health and/or more informed public valuations and (ii) the appropriate valuation
of health states considered to be worse than dead
• Methods for valuing health at different time points in a person’s life (e.g., at the end of life)
• Methods to determine whether public or patient valuations of health should be used in economic evaluation
• Methods for establishing opportunity cost of NICE guidance (i.e., the threshold) and empirical data on
interventions that are being displaced by NICE guidance
Web-based • Optimal methods for analyzing disease registers and other nonexperimental data sources
ranking • Methods to adjust for bias in meta-analysis
exercise • Methods for conducting systematic reviews of complex interventions
• Optimal methods for evaluating diagnostic and screening technologies
• Methods for conducting efficient systematic reviews
• Methods for the extrapolation of costs and benefits
• Research to assess whether the predictions of economic models are borne out in practice
• Methods to capture wider benefits not captured in the QALY
• Methods to assess whether additional evidence is needed before the routine introduction of interventions
(e.g., ‘only in research’ or ‘coverage with evidence’ decisions)
are as judged by a broad group of individuals with an interest
in NICE and/or evaluation methods.
Whereas the low response rate to the email survey from
international HTA agencies and other research organizations
may limit the generalizability of the findings to bodies other
than NICE, some of the methods research areas identified
are likely to be relevant to other organizations. The extent to
which the identified topics may also be priorities for other
national and international HTA and health evaluation bodies
(such as European network for Health Technology Assess-
ment – EUnetHTA) will depend on the similarity of methods
of evaluation to NICE and of the political, legal, and cultural
frameworks within which they operate.
There are numerous potential research topics that could
be commissioned to help NICE decision making. In terms
of setting research priorities, this study has highlighted the
variation in research priorities between different groups of
stakeholders with an interest in NICE decision making. Given
this variation, there is a need to consider carefully whose pri-
orities matter when funding research. The priorities of the
recipients of research (e.g., the decision maker) may dif-
fer from those who use the methods (e.g., academics or in-
dustry). The NIHR-MRC Methodology Research Program
has already provided funding to take nine of the identified
topics forward (9). The definition of methodological research
was raised throughout the process and needs to be consid-
ered as these topics are developed further. A large proportion
of suggested topics are clearly methodological in that they
relate to the further development and refinement of eval-
uative and analytical tools, which have relevance beyond
a single application. Other topics may be judged less obvi-
ously methodological. For example, the estimation of NICE’s
cost-effectiveness threshold might be considered empirical
rather than methodological, but there are likely to be several
methodological questions that relate to this research. This
needs to be further discussed by research commissioners to
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Table 3. Most Frequently Prioritized Topics in the Web Exercise by Type of Respondent (Percentage
Reporting ‘Very Important’ or ‘Important’)
Organization (na) Topic %
NICE (n = 10) 5_C_2: What criteria should be used for establishing ‘only in
research’ recommendations?
100
1_A_1: Establishing methods and rules for efficient systematic
reviews of effectiveness, diagnostic test accuracy and prognostic
factors (i.e., tackling the trade-off between efficiency and quality)
90
University (n = 48) 3_C_2: Extrapolation of estimates of costs and benefits of
interventions beyond those observed in trials, including the
quantification of uncertainty
82
5_E_2: Development of methods to produce guidance to the NHS on
the disinvestment of existing interventions
82
Industry (n = 8) 1_B_5: Methods for linking treatments into networks of evidence
where there is no direct evidence link
100
3_A_4: Should potential reductions in pharmaceutical prices over
time be reflected in economic analysis. If so, what methods should
be used?
100
3_D_1: Methods to develop ‘standardized’ and ‘approved’ models in
a given disease area, including parameter inputs
100
3_D_3: Research to assess whether the predictions of economic
models used to inform NICE guidance are borne out in practice
100
3_D_4: Methods for the use of surrogate or intermediate measures in
models
100
3:D_5: Development of criteria for selecting an appropriate structure
for a decision model given available evidence on disease prognosis
and the impact of alternative interventions
100
Other (n = 8) 1_A_1: Establishing methods and rules for efficient systematic
reviews of effectiveness, diagnostic test accuracy and prognostic
factors (i.e., tackling the trade-off between efficiency and quality)
100
1_B_4: Establishing the extent to which networks of evidence should
be expanded for NICE guidance in terms of conducting
cost-effective research
100
1_D_8: How best to present data for NICE Committees 100
1_F_3: How best to evaluate diagnostic and screening technologies 100
3_F_6: Methods to establish the type of economic model and
appraisal process that should be used to formulate guidance (When
is it necessary to commission development of a new economic
model?)
100
5_D_7: What are the best methods for determining the most
important clinical questions for a given topic?
100
aNumber of respondents that completed any of this section.
avoid ignoring those topics that do not fit into traditional
categories of research.
CONCLUSIONS
We reviewed the methods research priorities to improve
NICE decision making through a range of qualitative meth-
ods and a Web-based prioritization exercise. We found five
key areas of methodology for which research is needed to
support NICE decision making: evidence synthesis (includ-
ing indirect comparisons and the use of disease registers), the
use of qualitative evidence, the use of QALYs, establishing
the threshold for cost-effectiveness, and how uncertainty in
the evidence base should be reflected in NICE recommenda-
tions. Some research funding has already been made avail-
able to pursue some of the identified topics. Research com-
missioners should consider making further funding available,
including for those topic areas that do not fit into traditional
categories of research.
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